Medicare’s weight-loss drug Wegovy coverage poses potential premium hike for millions of enrollees
Medicare’s recent move to cover the weight-loss drug Wegovy for some recipients with heart disease risk could drive up the cost of monthly premiums for many of the 65 million...
Read more